Joint EU-UK pharmaceutical industry response to Specialised Committee outcome

9 November 2020

Failure to launch: white paper explores the role of inappropriate use of IP in blocking access to generic and biosimilar medicines

5 November 2020

Comunicato Stampa Assogenerici Assemblea Pubblica

22 October 2020

Open letter from Medicines for Europe Executive on the upcoming EU pharmaceutical strategy

20 October 2020

Statement from the President: Now or never: pragmatism & ambition needed in EU pharma strategy to deliver on Europe’s medicines manufacturing

7 October 2020

Berlin, 07 October 2020, speaking at ‘For a Healthy Europe’, […]

Am fost foarte mândru de eforturile industriei noastre de a uni și a pune interesul pacienților absolut pe primul loc în timpul acestei crize

5 October 2020

Interviu cu Adrian van den Hoven, director general Medicines for Europe  […]

IGBA: Global Roadmap for Tailored Clinical Biosimilar Development: Instrumental for Sustainable Access to Biologics

24 September 2020

Joint press statement of European Pharmaceutical industry associations

17 September 2020

Decisive action on medicines shortages should be included in pharmaceutical and industrial strategies

17 September 2020

Practical measures are paramount for robust medicines manufacturing

9 September 2020